The Urinary Excretion of Metabolites During Radiological Cell-Destruction in Leukaemic Patients
1958

Urinary Metabolites in Leukaemic Patients During Treatment

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): J. Gerbrandy, H. B. A. Hellendoorn, H. Lokkerbol

Primary Institution: Antoni van Leeuwenhoek-Huis, Netherlands Cancer Institute, Amsterdam

Hypothesis

The urinary excretion of metabolites will increase during the destruction of tumour tissue in leukaemic patients receiving radiological treatment.

Conclusion

The excess excretion of urinary phosphate serves as a rough quantitative measure of tumour loss in leukaemic patients undergoing treatment.

Supporting Evidence

  • The rise of urinary excretion of metabolites was closely related to the loss of tumour tissue during treatment.
  • Excess excretion of phosphate correlated with the estimated loss of leukaemic cells.
  • Patients with no measurable decrease in tumour tissue did not show a rise in metabolite excretion.

Takeaway

When leukaemic patients are treated with radiation, their bodies release more waste products from the dying cancer cells, which can help doctors understand how much cancer is being destroyed.

Methodology

The study measured urinary excretion of metabolites in 5 leukaemic and 3 cancer patients on a standardized diet during X-ray treatment.

Limitations

The study had a small sample size and only included specific types of leukaemia and cancer patients.

Participant Demographics

Included 5 leukaemic patients (2 with chronic myeloid leukaemia and 3 with chronic lymphoid leukaemia) and 3 cancer patients (2 with metastasized carcinoma and 1 with reticulosarcoma).

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication